ARTICLE | Company News
FDA approves Takeda's Rozerem ramelteon
July 22, 2005 11:53 PM UTC
FDA granted marketing approval to Takeda (Osaka, Japan) for Rozerem ramelteon to treat insomnia characterized by difficulty with sleep onset. Takeda said Rozerem is the only non-scheduled prescription...